Caribou Biosciences

Forecast & Rating6 analysts currently cover Caribou Biosciences, with about 33.3% giving a positive rating — meaning they expect the stock to rise. The average price target is $5.75, about 1057.2% upside from the current price of $0.50. Price targets range from $1.00 to $13.00 — a wide spread, showing clear disagreement over just how much Caribou Biosciences can rise. Historically, about 1.8% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Caribou Biosciences's outlook. Data as of Oct 8, 2026; for reference only and not investment advice.